Oral immunization with Shigella sonnei WRSs2 and WRSs3 vaccine strains elicits systemic and mucosal antibodies with functional anti-microbial activity시겔라 소네이 WRSs2 및 WRSs3 백신 균주로 경구 면역화하면 기능적인 항미생물 활성을 가진 전신 및 점막 항체가 유도됩니다.Article Published on 2024-01-302024-08-22 Journal: mSphere [Category] 세균성이질, [키워드] functional antibodies mucosal immunity oral vaccines Shigella
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccinearticle Published on 2023-11-302024-09-05 Journal: Journal of virology [Category] update2024, [키워드] Fc-effector functions functional antibodies respiratory syncytial virus Vaccines [DOI] 10.1128/jvi.00771-23 PMC 바로가기 [Article Type] article
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapyRandomized Controlled Trial Published on 2022-11-152023-07-10 Journal: Cell Reports Medicine [Category] COVID19(2023년), [키워드] antibody Fc glycosylation convalescent plasma COVID immunomodulation COVID-19 Fc effector functions functional antibodies immunodominance shift nucleocapsid SARS-CoV-2 systems serology. [DOI] 10.1016/j.xcrm.2022.100811 PMC 바로가기 [Article Type] Randomized Controlled Trial
Functional antibodies as immunological endpoints to evaluate protective immunity against Shigellaarticle Published on 2020-12-312024-09-01 Journal: Human vaccines & immunotherapeutics [Category] 세균성이질, [키워드] correlates of protection functional antibodies protective immunity Shigella threshold of protection trials for developing countries vaccinology [Article Type] article
SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsArticle Published on 2020-10-212023-07-11 Journal: Journal of Clinical Microbiology [Category] SARS, [키워드] ACE2 blocking assay COVID-19 functional antibodies SARS-CoV-2 SARS-CoV-2 immunity SARS-CoV-2 vaccine Serological tests [DOI] 10.1128/JCM.01533-20 PMC 바로가기
Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection이전 말라리아 노출의 혈청학적 마커와 기생충 성장 억제 기능 항체는 플라스모디움 팔시파룸 통제된 인간 감염 후 기생충 동역학과 관련이 있다.Article Published on 2020-06-152024-08-11 Journal: Clinical infectious diseases : an official publication of the Infectious [Category] 말라리아, [키워드] clinical outcomes Controlled human malaria infection functional antibodies Malaria exposure parasite kinetics [DOI] 10.1093/cid/ciz740 PMC 바로가기
Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate시겔라 플렉스네리 2a O-항원 바이오접합 백신 후보의 특성화 및 면역원성Article Published on 2019-09-172024-07-30 Journal: Glycobiology [Category] 세균성이질, [키워드] biosynthetic glycoconjugate vaccine Escherichia coli glycosylation functional antibodies immunogenicity Shigella flexneri 2a [DOI] 10.1093/glycob/cwz044 PMC 바로가기
Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella장독소 생성 대장균(ETEC), 캠필로박터 제주니 및 시겔라에 대한 접합 백신 플랫폼 평가Article Published on 2018-10-292024-08-22 Journal: Vaccine [Category] 세균성이질, [키워드] Campylobacter Conjugate vaccines ETEC functional antibodies Shigella [DOI] 10.1016/j.vaccine.2018.09.052
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase SubtypeArticle Published on 2018-08-162023-06-14 Journal: Journal of Virology [Category] Fulltext, 신종인플루엔자, [키워드] correlates of protection functional antibodies influenza A virus neuraminidase protein. VSV replicon vaccine platform [DOI] 10.1128/JVI.01006-18 PMC 바로가기
Functional and Antigen-Specific Serum Antibody Levels as Correlates of Protection against Shigellosis in a Controlled Human Challenge Study기능적 및 항원 특이적 혈청 항체 수준이 통제된 인간 도전 연구에서 시겔라증에 대한 보호의 상관관계로서Article Published on 2016-12-072024-07-30 Journal: Clin Vaccine Immunol [Category] 세균성이질, [키워드] correlates of protection functional antibodies Shigella [DOI] 10.1128/CVI.00412-16 PMC 바로가기